Annual Information Update

RNS Number : 1461B
AstraZeneca PLC
11 April 2012
 



ASTRAZENECA PLC

ANNUAL INFORMATION UPDATE

 

As required under the Prospectus (Directive 2003/71/EC) Regulations 2005 and paragraph 5.2 of the Prospectus Rules, and following publication of the Annual Report and Form 20-F Information on 26 March 2012, AstraZeneca PLC is presenting its Annual Information Update in relation to information that has been published or made available to the public between 08 April 2011 and 10 April 2012.

 

This Annual Information Update is also being made available on the Investors section of our website, www.astrazeneca.com.

 

The information referred to in this Annual Information Update was correct at the time it was published but may now be out of date.

 

1. Announcements made via a RIS

 

The documents listed below were published via a Regulatory Information Service on or around the dates indicated.

 

Date

Description of Contents of Announcement

08/04/11

Transaction in Own Shares

08/04/11

Annual Information Update

11/04/11

Transaction in Own Shares

12/04/11

Transaction in Own Shares

13/04/11

Transaction in Own Shares

14/04/11

Transaction in Own Shares

15/04/11

Transaction in Own Shares

18/04/11

Transaction in Own Shares

19/04/11

Transaction in Own Shares

20/04/11

Transaction in Own Shares

21/04/11

Transaction in Own Shares

26/04/11

Transaction in Own Shares

27/04/11

Transaction in Own Shares

27/04/11

Notice of Results

28/04/11

Transaction in Own Shares

28/04/11

1st Quarter Results (part 1 of 2)

28/04/11

1st Quarter Results (part 2 of 2)

28/04/11

Result of Meeting

28/04/11

Filing of Annual Report on SEC

03/05/11

03/05/11

04/05/11

04/05/11

04/05/11

05/05/11

06/05/11

06/05/11

06/05/11

10/05/11

11/05/11

12/05/11

13/05/11

16/05/11

17/05/11

18/05/11

19/05/11

20/05/11

23/05/11

24/05/11

24/05/11

25/05/11

26/05/11

27/05/11

31/05/11

01/06/11

01/06/11

01/06/11

Transaction in Own Shares

Total Voting Rights

Transaction in Own Shares

Director/PDMR Shareholding

Director/PDMR Shareholding

Transaction in Own Shares

Transaction in Own Shares

Share Repurchase Programme

Director/PDMR Shareholding

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Director/PDMR Shareholding

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Health Canada approves Brilinta

Total Voting Rights

02/06/11

03/06/11

06/06/11

07/06/11

08/06/11

09/06/11

10/06/11

13/06/11

14/06/11

15/06/11

15/06/11

16/06/11

17/06/11

20/06/11

21/06/11

22/06/11

22/06/11

23/06/11

24/06/11

27/06/11

27/06/11

28/06/11

29/06/11

30/06/11

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Director/PDMR Shareholding

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Sells Astra Tech to Dentsply International

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Announces Phase3 study with BMS on Dapagliflozin

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

01/07/11

Transaction in Own Shares

01/07/11

Nexium gets first approval in Japan

01/07/11

Total Voting Rights

04/07/11

Transaction in Own Shares

05/07/11

Transaction in Own Shares

06/07/11

Transaction in Own Shares

07/07/11

Transaction in Own Shares

08/07/11

Transaction in Own Shares

11/07/11

Transaction in Own Shares

12/07/11

Transaction in Own Shares

13/07/11

Transaction in Own Shares

14/07/11

Transaction in Own Shares

15/07/11

Transaction in Own Shares

18/07/11

Transaction in Own Shares

19/07/11

Transaction in Own Shares

20/07/11

Transaction in Own Shares

20/07/11

FDA advisors make recommendation on Dapagliflozin

21/07/11

Transaction in Own Shares

21/07/11

22/07/11

25/07/11

26/07/11

27/07/11

27/07/11

28/07/11

28/07/11

28/07/11

28/07/11

29/07/11

FDA approves Brilinta for us in the US

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Notice of Results

Transaction in Own Shares

Second Quarter Results 2011 - Part 1 of 3

Second Quarter Results 2011 - Part 2 of 3

Second Quarter Results 2011 - Part 3 of 3

Transaction in Own Shares

01/08/11

Transaction in Own Shares

01/08/11

Total Voting Rights

02/08/11

03/08/11

04/08/11

05/08/11

08/08/11

09/08/11

10/08/11

10/08/11

11/08/11

12/08/11

12/08/11

15/08/11

17/08/11

18/08/11

19/08/11

22/08/11

23/08/11

24/08/11

24/08/11

25/08/11

26/08/11

26/08/11

30/08/11

30/08/11

31/08/11

31/08/11

31/08/11

01/09/11

01/09/11

02/09/11

02/09/11

05/09/11

06/09/11

07/09/11

08/09/11

09/09/11

12/09/11

13/09/11

13/09/11

13/09/11

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Director/PDMR Shareholding

Transaction in Own Shares

Transaction in Own Shares

Director/PDMR Shareholding

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Block Listing Application

Transaction in Own Shares

Transaction in Own Shares

Share Repurchase Programme

Transaction in Own Shares

Director/PDMR Shareholding

Transaction in Own Shares

Sale of AstraTech to DENTSPLY complete

Director/PDMR Shareholding

Transaction in Own Shares

Total Voting Rights

Transaction in Own Shares

Top-Line Results from SATURN study

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

Block Listing Application

Block Listing Six Month Interim Review

14/09/11

Transaction in Own Shares

15/09/11

Transaction in Own Shares

16/09/11

Transaction in Own Shares

19/09/11

Transaction in Own Shares

20/09/11

Transaction in Own Shares

21/09/11

Transaction in Own Shares

22/09/11

Transaction in Own Shares

23/09/11

Transaction in Own Shares

23/09/11

Komboglyze receives positive CHMP opinion

26/09/11

Transaction in Own Shares

27/09/11

Transaction in Own Shares

28/09/11

Transaction in Own Shares

29/09/11

Transaction in Own Shares

30/09/11

Transaction in Own Shares

30/09/11

US Seroquel XR Patent Litigation

30/09/11

Share Repurchase Programme

03/10/11

Transaction in Own Shares

03/10/11

Total Voting Rights

04/10/11

Transaction in Own Shares

05/10/11

Transaction in Own Shares

05/10/11

Settles with Accord and Intas over Seroquel XR

06/10/11

Transaction in Own Shares

07/10/11

Transaction in Own Shares

10/10/11

Transaction in Own Shares

11/10/11

Transaction in Own Shares

12/10/11

Transaction in Own Shares

13/10/11

Transaction in Own Shares

14/10/11

Transaction in Own Shares

17/10/11

Transaction in Own Shares

18/10/11

Transaction in Own Shares

19/10/11

Transaction in Own Shares

20/10/11

Transaction in Own Shares

21/10/11

Transaction in Own Shares

24/10/11

Transaction in Own Shares

25/10/11

Transaction in Own Shares

26/10/11

Transaction in Own Shares

26/10/11

Notice of Results

27/10/11

Transaction in Own Shares

27/10/11

3rd Quarter Results - Part 1 of 2

27/10/11

3rd Quarter Results - Part 2 of 2

27/10/11

FDA extends Dapa action date by three months

28/10/11

Transaction in Own Shares

28/10/11

Director/PDMR Shareholding

31/10/11

Transaction in Own Shares

01/11/11

Transaction in Own Shares

01/11/11

Total Voting Rights

02/11/11

Transaction in Own Shares

03/11/11

Transaction in Own Shares

04/11/11

Transaction in Own Shares

07/11/11

Transaction in Own Shares

08/11/11

Transaction in Own Shares

08/11/11

First top line results for TC-5214 with Targacept

09/11/11

Transaction in Own Shares

10/11/11

Transaction in Own Shares

11/11/11

Transaction in Own Shares

14/11/11

Transaction in Own Shares

15/11/11

Transaction in Own Shares

16/11/11

Transaction in Own Shares

17/11/11

Transaction in Own Shares

18/11/11

Transaction in Own Shares

21/11/11

Transaction in Own Shares

22/11/11

Transaction in Own Shares

23/11/11

Transaction in Own Shares

24/11/11

Transaction in Own Shares

25/11/11

Transaction in Own Shares

28/11/11

Transaction in Own Shares

29/11/11

Transaction in Own Shares

29/11/11

Komboglyze gets EU marketing authorisation

30/11/11

Transaction in Own Shares

01/12/11

Transaction in Own Shares

01/12/11

Total Voting Rights

01/12/11

Blocklisting Interim Review

02/12/11

Transaction in Own Shares

05/12/11

Transaction in Own Shares

06/12/11

Transaction in Own Shares

07/12/11

Transaction in Own Shares

08/12/11

Transaction in Own Shares

08/12/11

AstraZeneca streamlines US sales organisation

09/12/11

Transaction in Own Shares

12/12/11

Transaction in Own Shares

13/12/11

Transaction in Own Shares

14/12/11

Transaction in Own Shares

15/12/11

Transaction in Own Shares

15/12/11

Share Repurchase Programme

16/12/11

Transaction in Own Shares

19/12/11

Transaction in Own Shares

20/12/11

Transaction in Own Shares

20/12/11

Updates on Olaparib and TC-5214 programmes

21/12/11

Transaction in Own Shares

22/12/11

Transaction in Own Shares

23/12/11

Transaction in Own Shares

29/12/11

Transaction in Own Shares

03/01/12

Total Voting Rights

04/01/12

Transaction in Own Shares

04/01/12

Director/PDMR Shareholding

05/01/12

Transaction in Own Shares

06/01/12

Transaction in Own Shares

09/01/12

Transaction in Own Shares

09/01/12

Reaffirms financial guidance for 2011

10/01/12

Transaction in Own Shares

11/01/12

Transaction in Own Shares

12/01/12

Transaction in Own Shares

13/01/12

Transaction in Own Shares

16/01/12

Transaction in Own Shares

18/01/12

Transaction in Own Shares

19/01/12

FDA complete response letter for Dapagliflozin

19/01/12

Transaction in Own Shares

20/01/12

Transaction in Own Shares

23/01/12

Transaction in Own Shares

24/01/12

Transaction in Own Shares

25/01/12

Transaction in Own Shares

26/01/12

Transaction in Own Shares

27/01/12

Transaction in Own Shares

30/01/12

Transaction in Own Shares

31/01/12

Transaction in Own Shares

01/02/12

Transaction in Own Shares

01/02/12

Notice of Results

01/02/12

Total Voting Rights

02/02/12

Final Results - Part 1 of 3

02/02/12

Final Results - Part 2 of 3

02/02/12

Final Results - Part 3 of 3

02/02/12

Transaction in Own Shares

02/02/12

Share Repurchase Programme

03/02/12

Transaction in Own Shares

03/02/12

Director/PDMR Shareholding

03/02/12

Holding(s) in Company

06/02/12

Transaction in Own Shares

07/02/12

Transaction in Own Shares

08/02/12

Transaction in Own Shares

09/02/12

Transaction in Own Shares

10/02/12

Transaction in Own Shares

13/02/12

Transaction in Own Shares

14/02/12

Transaction in Own Shares

15/02/12

Transaction in Own Shares

16/02/12

Transaction in Own Shares

16/02/12

Director Declaration

17/02/12

Transaction in Own Shares

20/02/12

Transaction in Own Shares

21/02/12

Transaction in Own Shares

21/02/12

EU approves Caprelsa for thyroid cancer

22/02/12

Transaction in Own Shares

23/02/12

Transaction in Own Shares

24/02/12

Transaction in Own Shares

27/02/12

Transaction in Own Shares

27/02/12

Director/PDMR Shareholding

27/02/12

Director/PDMR Shareholding

27/02/12

Director/PDMR Shareholding

28/02/12

Transaction in Own Shares

28/02/12

Director/PDMR Shareholding

28/02/12

Director/PDMR Shareholding

28/02/12

Director/PDMR Shareholding

29/02/12

Transaction in Own Shares

01/03/12

Announces Non-Executive and Chairman changes

01/03/12

Total Voting Rights

02/03/12

Transaction in Own Shares

02/03/12

Share Repurchase Programme

06/03/12

Transaction in Own Shares

07/03/12

Transaction in Own Shares

08/03/12

Transaction in Own Shares

09/03/12

Transaction in Own Shares

12/03/12

Transaction in Own Shares

13/03/12

Transaction in Own Shares

13/03/12

Files lawsuit against FDA decision on quetiapine

14/03/12

Transaction in Own Shares

15/03/12

Transaction in Own Shares

16/03/12

Transaction in Own Shares

19/03/12

Transaction in Own Shares

20/03/12

Transaction in Own Shares

20/03/12

TC-5214 Phase III studies do not meet endpoint

21/03/12

Transaction in Own Shares

22/03/12

Transaction in Own Shares

22/03/12

UK Court finds Seroquel XR patent invalid

23/03/12

Transaction in Own Shares

26/03/12

US Court dismisses lawsuit against the FDA

26/03/12

Transaction in Own Shares

26/03/12

Annual Financial Report

27/03/12

Transaction in Own Shares

28/03/12

Transaction in Own Shares

28/03/12

Director/PDMR Shareholding

28/03/12

Director/PDMR Shareholding

28/03/12

Director/PDMR Shareholding

29/03/12

Transaction in Own Shares

29/03/12

Filing of Annual Report on Form 20-F with SEC

29/03/12

Director/PDMR Shareholding

30/03/12

US Court Finds Seroquel XR Patent Valid

30/03/12

Transaction in Own Shares

30/03/12

Director/PDMR Shareholding

02/04/12

Transaction in Own Shares

02/04/12

Total Voting Rights

02/04/12

Director/PDMR Shareholding

02/04/12

Director/PDMR Shareholding

02/04/12

Director/PDMR Shareholding

02/04/12

Director/PDMR Shareholding

03/04/12

Transaction in Own Shares

03/04/12

Partners Amgen to develop inflammation portfolio

04/04/12

Transaction in Own Shares

05/04/12

Transaction in Own Shares

10/04/12

Transaction in Own Shares

 

All of the above documents are available for download on the Prices and News section of the London Stock Exchange website, www.londonstockexchange.com.

 

2. Documents filed at Companies House

 

The documents listed below were filed with the Registrar of Companies in England and Wales on or around the dates indicated.

 

Date

Document type



15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

15/04/11

Form SH03 - Return of Purchase of Own Shares

18/04/11

Form CH01 - Change of Director's Details

06/05/11

Form TM01 - Resignation of Director

10/05/11

Resolutions of Annual General Meeting

21/06/11

Form AR01 - Annual Return made up to 15/05/11

21/06/11

Group Accounts made up to 31/12/10

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

07/07/11

Form SH03 - Return of Purchase of Own Shares

08/07/11

Form SH03 - Return of Purchase of Own Shares

24/08/11

Form SH03 - Return of Purchase of Own Shares

24/08/11

Form SH03 - Return of Purchase of Own Shares

24/08/11

Form SH03 - Return of Purchase of Own Shares

24/08/11

Form SH03 - Return of Purchase of Own Shares

24/08/11

Form SH03 - Return of Purchase of Own Shares

24/08/11

Form SH03 - Return of Purchase of Own Shares

24/08/11

Form SH03 - Return of Purchase of Own Shares

24/08/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

10/10/11

Form SH03 - Return of Purchase of Own Shares

02/12/11

Form SH03 - Return of Purchase of Own Shares

02/12/11

Form SH03 - Return of Purchase of Own Shares

02/12/11

Form SH03 - Return of Purchase of Own Shares

02/12/11

Form SH03 - Return of Purchase of Own Shares

02/12/11

Form SH03 - Return of Purchase of Own Shares

02/12/11

Form SH03 - Return of Purchase of Own Shares

06/12/11

Form AD02 - Change of SAIL Address

10/01/12

Form SH03 - Return of Purchase of Own Shares

10/01/12

Form SH03 - Return of Purchase of Own Shares

10/01/12

Form SH03 - Return of Purchase of Own Shares

10/01/12

Form SH03 - Return of Purchase of Own Shares

10/01/12

Form SH03 - Return of Purchase of Own Shares

10/01/12

Form SH03 - Return of Purchase of Own Shares

10/01/12

Form SH03 - Return of Purchase of Own Shares

10/01/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

20/02/12

Form SH03 - Return of Purchase of Own Shares

16/03/12

Form SH03 - Return of Purchase of Own Shares

16/03/12

Form SH03 - Return of Purchase of Own Shares

16/03/12

Form SH03 - Return of Purchase of Own Shares

16/03/12

Form SH03 - Return of Purchase of Own Shares

20/03/12

Form CH01 - Change of Director's Details

10/04/12

Form SH03 - Return of Purchase of Own Shares

10/04/12

Form SH03 - Return of Purchase of Own Shares

10/04/12

Form SH03 - Return of Purchase of Own Shares

 

All of the documents above are available for download from the Companies House website at www.companieshouse.gov.uk, or can be obtained from Companies House, Crown Way, Maindy, Cardiff, CF14 3UZ.

 

3. Documents submitted to the FSA

 

The documents listed below were submitted to The National Storage Mechanism (NSM) on or around the dates indicated.

 

Date

Document

 

 

26/03/12

Letter from the Chairman

26/03/12

Notice of AGM 2012 and Shareholder's Circular

26/03/12

AstraZeneca 2011 In Brief

26/03/12

AstraZeneca Annual Report and Form 20-F Information 2011

 

All of the above documents are available for download from the NSM website at www.Hemscott.com/nsm.do. The Letter from the Chairman, Notice of AGM 2012, AstraZeneca 2011 In Brief and Annual Report and Form 20-F Information 2011 are also available via the Investors section of our website, www.astrazeneca.com.

 

 

4. Documents lodged with the Securities and Exchange Commission

 

The documents listed below were filed with the SEC on or around the dates indicated.

 

Date

Document

 

 

08/04/11

Form 6-K

28/04/11

Form 20-F

03/05/11

Form F-6EF

09/05/11

Form 6-K

03/06/11

Form 6-K

07/07/11

Form 6-K

02/08/11

Form 6-K

02/09/11

Form 6-K

07/10/11

Form 6-K

07/11/11

Form 6-K

09/12/11

Form 6-K

04/01/12

Form 6-K

06/02/12

Form 6-K

13/02/12

Form SC 13G/A

05/03/12

Form 6-K

28/03/12

Form 20-F

05/04/12

Form 6-K

 

All of the documents above are available for viewing on the Investor section of our website, www.astrazeneca.com.

 

 

 

 

5.  Further Information

 

Further information about AstraZeneca PLC can be found at our website, www.astrazeneca.com.

 

A C N Kemp

Company Secretary

11 April 2012

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUIBMJTMBTBBFT

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings